The Pan-Immune-Inflammation Value predicts the survival of patients with anaplastic lymphoma kinase-positive non-small cell lung cancer treated with first-line ALK inhibitor-Reference-Cited by-全球学者库

The Pan-Immune-Inflammation Value predicts the survival of patients with anaplastic lymphoma kinase-positive non-small cell lung cancer treated with first-line ALK inhibitor

Published:2022-03 Issue: Volume:17 Page:101338
ISSN:1936-5233
Container-title:Translational Oncology
language:en
Short-container-title:Translational Oncology

Author:

Chen Xinru,Hong Xiangchan,Chen Gang,Xue Jinhui,Huang Jie,Wang Fan,Ali Wael Ab dullah Sultan,Li Jing,Zhang Li

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference41 articles.

1. The incidence and mortality of lung cancer and their relationship to development in Asia;Pakzad;Transl. Lung Cancer Res.,2015

2. EML4-ALK fusion gene and efficacy of an ALK kinase inhibitor in lung cancer;Koivunen;Clin. Cancer Res.,2008

3. ALK inhibitors in the treatment of advanced NSCLC;Gridelli;Cancer Treat. Rev.,2014

4. First-line crizotinib versus chemotherapy in ALK-positive lung cancer;Solomon;N. Engl. J. Med.,2014

5. Updated efficacy and safety data and impact of the EML4-ALK fusion variant on the efficacy of alectinib in untreated ALK-positive advanced non-small cell lung cancer in the global phase III ALEX study;Camidge;J. Thorac. Oncol.,2019

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Saliva as a potential non-invasive liquid biopsy for early and easy diagnosis/prognosis of head and neck cancer;Translational Oncology;2024-02

2. High pre-chemoradiotherapy pan-immune-inflammation value levels predict worse outcomes in patients with stage IIIB/C non-small-cell lung cancer;Discover Oncology;2023-12-13

3. A Novel Prognostic Model Using Pan-Immune-Inflammation Value and Programmed Death Ligand 1 in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Receiving Immune Checkpoint Inhibitors: A Retrospective Multicenter Analysis;Targeted Oncology;2023-12-02

4. Predictive value of platelet-to-lymphocyte ratio combined with CA199 levels in postoperative survival of patients with gastric cancer: A retrospective study;International Immunopharmacology;2023-11

5. Prognostic significance of the pretreatment pan-immune-inflammation value in cancer patients: an updated meta-analysis of 30 studies;Frontiers in Nutrition;2023-10-02